Alyeska Investment Group
STDY

Alyeska Investment Group’s SteadyMed Ltd STDY Stock Holding History

Alyeska Investment Group’s Portfolio STDY Stock Details STDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-85,000
Closed -$723K – 618
2015
Q1 		$723K Buy
+85,000
New +$728K 0.01% 453

Other funds holding STDY

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
BCCM
Blue Clay Capital Management Minneapolis, Minnesota $88.7M AUM 6.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MPMG
Minneapolis Portfolio Management Group Wayzata, Minnesota $1.06B AUM 63.37% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Alyeska Investment Group's STDY Position: Q2 2015 in Review

Alyeska Investment Group sold out of SteadyMed Ltd (STDY) in Q2 2015, closing a stake of 85,000 shares — an estimated $723K sold.

Alyeska Investment Group first reported a position in STDY in Q1 2015 and held it in 1 quarter. The position peaked at $723K in Q1 2015. 15 funds tracked by Wall St. Rank hold STDY as of Q2 2015.

  • Alyeska Investment Group reported no remaining SteadyMed Ltd position as of Q2 2015 after selling out during the quarter.
  • Alyeska Investment Group sold 85,000 SteadyMed Ltd shares in Q2 2015, an estimated $723K.
  • Alyeska Investment Group first reported a position in SteadyMed Ltd in Q1 2015 and held it in 1 quarter.
  • Alyeska Investment Group's SteadyMed Ltd position peaked at $723K in Q1 2015.
  • 15 funds tracked by Wall St. Rank held SteadyMed Ltd as of Q2 2015.

Based on Alyeska Investment Group's 13F filing for Q2 2015, filed 14 Aug 2015.